Learn More
Selleck Chemical LLC BIIB129 E4643-5MG

Supplier: Selleck Chemical LLC E46435MG
BIIB129 is a unique brain-penetrant covalent inhibitor of Bruton s tyrosine kinase (BTK) with high kinome selectivity It exhibits efficacy in targeting B-cell proliferation in the central nervous system (CNS) making it a promising immunomodulatory therapy for multiple sclerosis (MS)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.